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Abstract
The dopamine D1 receptor (D1R), a G protein-coupled receptor, plays a critical role in regulating blood pressure through its
actions on renal hemodynamics and epithelial ion transport, which are highly linked to its intracellular trafficking. In this
study, we generated a series of C-terminal mutants of D1R that were tagged with or without enhanced yellow fluorescent
protein, and analyzed the consequences of these mutants on the plasma membrane trafficking of D1R and cyclic AMP
response to D1R stimulation. D1R with mutations within the endocytic recycling signal (amino acid residues 360–382)
continued to be functional, albeit decreased relative to wild-type D1R. Mutation of the palmitoylation site (347C.S) of D1R
did not impair its trafficking to the plasma membrane, but abolished its ability to increase cyclic AMP accumulation. In
contrast, replacement of di-leucines (344–345L.A) by alanines resulted in the retention of D1R in the early endosome,
decreased its glycosylation, and prevented its targeting to the plasma membrane. Our studies suggest that di-L motif at the
C-terminus of D1R is critical for the glycosylation and cell surface targeting of D1R.
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Introduction
Dopamine, produced in the kidney, known to play an important
role in regulating renal sodium excretion [1], produces its
biological effects through five genetically distinct dopamine
receptors in mammals [2]. It has been reported that defective
dopamine receptor function, especially the dopamine D1 receptor
(D1R), in the kidney is found in humans with essential
hypertension [3]. Deletion of any of the dopamine receptor genes,
including the D1R, in mice produces hypertension, the pathogen-
esis of which is specific to the particular dopamine receptor
subtype [4,5]. Dopamine receptors belong to a large family of G
protein-coupled receptors (GPCRs) that sense molecules outside
the cell and activate inside signal transduction pathways and,
ultimately, cellular responses. There are two principal signal
transduction pathways involving GPCRs: the cyclic AMP (cAMP)
pathway and the phosphatidylinositol pathway [6]. Based on their
ability to stimulate or inhibit adenylyl cyclase, dopamine receptors
are classified into two major sub-families the D1-like (D1R and
D5R) and D2-like (D2R, D3R, and D4R) dopamine receptors,
respectively [7].
As with all surface membrane receptors, the function of GPCRs
is tightly linked to their intracellular trafficking. Their trafficking to
the plasma membrane is needed for response to their extracellular
ligand. Therefore, the appropriate delivery of GPCRs to the
plasma membrane permits receptor/ligand interaction. Their
subsequent internalization and re-insertion to the plasma mem-
brane are of fundamental importance in the regulation of GPCR
activity.
Several studies have shown that the C-terminus of D1R plays an
important role in its plasma membrane trafficking. Vargas and von
Zastrow[8] identifiedanovelendocyticrecycling signal (amino acids
360–382)intheC-terminusofD1R.Bermaketal.[9]reported that a
carboxy-terminal hydrophobic motif, F333XXXF337XXXF341,
which is highly conserved among GPCRs, functioned independently
as an endoplasmic reticulum (ER)-export signal for the D1R. It was
furtherdemonstrated that F337(X)6L344L345playsaroleinERexport
of several GPCRs, including a1B-AR, a2B-AR, AT1R, and b2-AR
[10,11]. Furthermore, di-leucine mutant 5-HT1AR gets stuck in ER,
indicating that the C-terminal di-leucine motif is involved in the
proper folding of 5-HT1AR [12]. However, in other integral
membrane proteins, the di-leucine motif typically plays a critical
role in internalization and lysosomal or plasma membrane targeting
[13,14].
To characterize further the structural determinants involved in
the trafficking of D1R from the ER to the plasma membrane, we
generated a series of C-terminal mutants of D1R and analyzed their
trafficking and function following agonist stimulation. Our results
indicated that di-L motif is critical for the plasma membrane
targeting of D1R. However, the internalized D1R continues to be
functional, if stimulated by a cell permeable agonist.
Materials and Methods
DNA Constructs
The complete coding sequence of human D1R was amplified by
PCR with Hind III digestion site at the N-terminus and Sac II
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mammalian expression vector pEYFP-N1 (Clontech, Mountain
View, CA) to generate pYG1 (pEYFP-hD1R). Then pYG1 was
utilized in producing C-terminal mutants of D1R (pYG2-pYG16)
(Fig. 1A and B), using the QuikChange site-directed mutagenesis
kit (Stratagene, La Jolla, CA). To ensure that the YFP tagging does
not interfere with the ligand binding, trafficking, or signaling of
D1R, the constructs of wild-type D1R and di-L mutant that do not
have YFP tags were also generated by putting a stop codon right
before YFP in pYG1 and pYG2, respectively.
All constructs generated and used in this study (Fig. 1B) were
confirmed by sequencing the complete open reading frame. All
primer sequences are listed in Table 1.
Cell Cultures and Transfections
Human embryonic kidney (HEK) 293 cells (ATCC, Manassas,
VA) were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% heat-inactivated fetal bovine serum
(ATCC, Manassas, VA) at 37uC with 95% air and 5% CO2.
For transient transfections, cells were grown on the coverslips in 6-
well plates and transfected at a ratio of 1 mg of plasmid DNA to
5 mL Lipofectamine 2000 (Invitrogen, CA) in 200 mL of serum-
free medium, according to the manufacturer’s protocol. The cells
were processed ,36 h after transfection for confocal microscopy
or western blotting. Transfection efficiency was estimated to be
same for each transfected plasmid based on the YFP fluorescence,
using an epifluorescence microscope.
Indirect Immunofluorescence
After transfection for ,36 hours, HEK 293 cells grown on
coverslips were rinsed in cold PBS and fixed with 4% paraformal-
dehyde for 20 min on ice, and then permeabilized with methanol
for 20 min on ice. The following primary antibodies were used:
monoclonal mouse anti-GM130 and monoclonal mouse anti-
calnexin (BD Transduction Laboratories, Bellevue, WA), and
polyclonal rabbit anti-EEA1 (Abcam, Cambridge, MA). Alexa
Fluor568 donkeyanti-mouse IgGandAlexaFluor568donkeyanti-
rabbit IgG were purchased from Invitrogen. Mounting medium
with DAPI (Vector Laboratory, Burlingame, CA) was used. Images
wereobtainedonOlympusFluoviewFV300laserscanningconfocal
microscopeequipped witha40X1.4N.A.objective.FITCfilterwas
used for imaging YFP-tagged proteins and the green color was
Figure 1. Cytoplasmic C-terminal domain of human D1R and constructs generated and used in this study. (A) The C-terminus of the
human D1R contains a di-leucine motif (L344-345), two palmitoylation sites (in green, C347 and C351), and an endocytic recycling signal (in blue,
amino acid residues 360–382). Three phenylalanine residues, in red, are highly conserved among GPCRs, function independently as an endoplasmic
reticulum (ER)-export signal for the D1R. TMD7 stands for transmembrane domain 7. (B) 12 D1R constructs were generated using site-directed
mutagenesis.
doi:10.1371/journal.pone.0029204.g001
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Imageswereprocessed using Adobe Photoshop.At least four studies
were performed for any particular transfection. About 300
randomly selected transfected cells per coverslip were observed.
The colocalization analysis was performed using Image J software.
Cell Surface Biotinylation and Isolation
HEK 293 cells were cultured in 10-cm dishes and transfected
with YFP-wild-type (wt) D1R or YFP-di-L D1R plasmid for cell
surface biotinylation and isolation studies, using a kit from
Thermo Scientific Pierce (Rockford, IL). In this study, one 10-
cm dish of cells for each plasmid was used. Twenty-four hours
after transfection the media were aspirated and cells quickly
washed twice with 5 mL of ice-cold PBS per dish. Then, 5 mL of
the biotin solution were added to each dish and gently agitated for
30 min at 4uC. At the end of 30 min, the reaction was stopped by
the addition of 500 mL of quenching solution. The rest of the steps
followed the manufacturer’s protocol. The samples were subjected
to SDS-PAGE, and then immunoblotted with anti-GFP antibody.
Western Blotting
Cells grown in 6-well plates were washed twice with ice-cold
PBS and then lysed in cold RIPA buffer containing 1 mM DTT
and protease and phosphatase inhibitors (Sigma, St. Louis, MO)
on ice for 10 min. The cells in each well were scraped and
transferred to a 2 ml centrifuge tube. The lysates were centrifuged
at 12,000 rpm in a pre-cooled centrifuge for 15 min and the
supernatants were transferred to new tubes. The lysates were
subjected to SDS-PAGE (4–12% gradient gel from Invitrogen) and
immunoblotted with specific antibodies. Li-Cor Odyssey infrared
imaging system (Li-Cor Biosciences, Lincoln, NE) was used for
western blotting detection.
Goat polyclonal anti-GFP antibody purchased from Abcam
(Cambridge, MA), which is designed to recognize all variants of
GFP, was used for blotting all YFP-tagged proteins in this study.
Rabbit anti-D1R antibody was from Origene (Rockville, MD).
Secondary antibodies were all purchased from Li-Cor Biosciences
(Lincoln, NE).
State of Glycosylation Analysis
HEK 293 cells grown in the 6-well plates were transfected with
same amount of pYG1 (YFP-wt D1R), pYG2 (YFP-di-L D1R),
pYG15 (wt D1R), and pYG16 (di-L D1R). After an 8 hr
transfection, the cells were treated with or without tunicamycin
(TUN; 1 mg/ml; Sigma, St. Louis, MO) for another 16 hr. Then
the cells were collected for western blotting following the steps
mentioned above. To determine the oligosaccharides in the
glycosylated D1R, 36 hr post-transfection, the cells were collected
and denatured in glycoprotein denaturing buffers (New England
Biolabs, Ipswich, MA) at 100uC for 10 min. Denatured sampled
were digested with 500 U endoglycosidase H or peptide-N4-(N-
acetyl-beta-glucosaminyl) asparagine amidase F (New England
Biolabs) by incubation at 37uC for 1 hr. After digestion, samples
were subjected to western blotting as mentioned above to analyze
their state of glycosylation.
Measurement of Cyclic AMP (cAMP) Production
HEK 293 cells were cultured in 6-well plates and then
transfected with different D1R plasmids; non-transfected cells
were included as negative control. 24 hr later, cells were treated
with vehicle or the cell-membrane permeable D1R agonist (in the
absence of D5R) fenoldopam (1 mM, 15 min) (Sigma, St. Louis,
MO), or the cell-membrane impermeable D1R agonist (in the
absence of D5R), A-68930 hydrochloride (1 mM, 15 min) (Sigma,
St. Louis, MO). The cells were concomitantly treated with a
phosphodiesterase inhibitor, IBMX (1 mM 3-isobutyl-1-methyl-
xanthine, Sigma, St. Louis, MO). After the 15 min incubation
period, 300 mL of 0.1 M HCl were added and incubated for
another 20 min at room temperature. The amount of cAMP in
each well containing $ 1 mg protein/ml was measured by an
immunoassay kit (BioVision, Mountain View, CA), according to
the manufacturer’s protocol. Each treatment was performed in
triplicate.
Data were expressed as mean + standard error. Significant
differences between two groups were determined by Student’s t
test. A P value , 0.05 was considered significant.
Results
As shown in Fig. 1A, the C-terminus of D1R contains a di-
leucine motif (L344/345) that is very close to the 7
th transmem-
brane domain (TMD 7), two palmitoylation sites (C347/351), and
an endocytic recycling signal sequence (T360—S382) identified by
Vargas and von Zastrow [8]. Bermak et al. [9] also reported that a
carboxy-termimal hydrophobic motif, FxxxFxxxF (F shown in red
in Fig. 1A), which is highly reserved among GPCRs, functions
independently as an ER-export signal for D1R. To study further
Table 1. Primers for site-directed mutagenesis.
Primers Sequences Constructs generated
nYG7 59-cggaaggcattttcaacggcggcaggatgctacagactttgccc-39 pYG2
nYG9 59-tggggcggcgatggcatccagccatcatg-39 pYG3
nYG13 59-gcgatgttttccagcgctgctgcgccacgaggctccatc-39 pYG4
nYG14 59-ccagccatcatgaggcagcagcctccatctccaaggag-39 pYG5
nYG15 59-catgagccacgaggcgccgccgccaaggagtgcaatctg-39 pYG6
nYG12 59-ggggccgcgatggctgccgcccatcatgagccac-39 pYG7
nYG17 59-caaccctcttaggaggctacagactttgc-39 pYG8
nYG9 59-gaataatgccatagaggcggcggctgccaataacaatggggcc-39 pYG9
nYG10 59-gccatagagacggtggctgccaataacaatggggc-39 pYG10
nYG5 59-cacccaaccccgcggtaggatccaccggtcgcc-39 pYG15 (pYG1 as template)
pYG16 (pYG2 as template)
doi:10.1371/journal.pone.0029204.t001
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function, the di-leucine motif (L344/L345) and a series of amino
acids within the endocytic recycling signal were mutated to alanine
residues using site-directed mutagenesis; one palmitoylation site
cysteine (C347) was replaced by a serine residue using the same
technique (Fig. 1B). All constructs, except pYG15 and pYG16,
were tagged with an enhanced YFP epitope at their C-termini in
order to facilitate the visual evaluation of transfection efficiency
and intracellular trafficking. All primer sequences are listed in
Table 1.
Di-leucine motif in the C-terminus of D1R is required for
its plasma membrane trafficking
We have studied the function of dopamine receptors in the
kidney [3–5]. Therefore, HEK 293 cells were used as the in vitro
model to express D1R. We have reported that HEK 293 cells do
not express endogenously D1R or the other D1-like receptor, D5R
[15–16], which was re-confirmed by immunoblotting and RT-
PCR in the current report (data not shown). All constructs listed in
Fig. 1B were transiently transfected into HEK 293 cells using
Lipofectamine 2000 transfection reagent. The transfected cells
were fixed ,36 hrs post-transfection for confocal microscopy. As
shown in Fig. 2A, the wild-type D1R was localized at the cell
surface, which is consistent with previous reports, including those
from our laboratory [15]. In contrast, di-leucine (Di-L) mutant
D1R was localized in punctate intracellular compartments. All
other mutants were trafficked to the plasma membrane as the
wild-type D1R, including the C347S mutant in which a pal-
mitoylation site was mutated, shown in Fig. 2A. Since the cell
distribution of di-L mutant was very different from the rest of the
mutants, we then detected its protein expression in transfected
HEK 293 cells by western blot using anti-GFP antibody (Fig. 2B)
and anti- D1R antibody (Supplemental Fig. S1). YFP-wt D1R
showed a band of ,90kDa and another band of ,70kDa. By
contrast, the di-L mutant also had a major band of ,70kDa, but
weak ,90kDa. Both proteins had lager bands ($160kDa), which
could be the aggregation of the proteins. When blotted with anti-
GFP antibody (Fig. 2B), both YFP-wt D1R and di-L mutant had a
,30 kDa that may represent the soluble YFP (27kDa). The bands
of ,40–50 kDa were probably degraded D1Rs. We have
previously reported [15] that the $90kDa bands are N-linked
glycosylated proteins, located at the cell membrane. Glycosylation
is necessary for the insertion of the D1R to the plasma membrane
[17]. The C-terminal di-leucine mutant 5-HT1A which is poorly
glycosylated does not traffic to the plasma membrane [12]. Taken
together, our studies suggest that di-L mutant D1R may not be
fully glycosylated and fails to be targeted to the cell surface,
suggesting that di-leucine motif in the C-terminus of D1R plays an
important role in its plasma membrane trafficking.
To investigate further whether or not di-L mutant D1R could
traffic to the plasma membrane, we studied the cell trafficking of
Figure 2. Trafficking of D1R C-terminal mutants. (A) HEK 293 cells transfected with YFP-tagged D1R plasmids grown on coverslips, and were
fixed ,36 hours post-transfection and subjected to confocal microscopy. Di-L and C347S were chosen as the representatives of the mutants. (B) HEK
293 cells were transfected with YFP-wt D1R and YFP-di-L D1R plasmids in 6-well plates. 36 hours after transfection, cells were washed twice with ice-
cold PBS and then lysed in cold RIPA buffer containing 1 mM DTT and protease and phosphatase inhibitors on ice for 10 min. The cell lysates were
subjected to SDS-polyacryalmide gel electrophoresis (4–12% gradient gel) and immunoblotted with goat-anti GFP antibody. (C) HEK 293 cells were
cultured in 10-cm dishes and then transfected with same amount of YFP-wt D1R and YFP-di-L D1R plasmids. Cell surface biotinylation and isolation
were performed using the commercial kit ,24 h post-transfection. Non-transfected cells were included as a negative control. Samples were then
immunoblotted with anti-GFP and anti-actin antibodies. W stands for whole cell lysate. F stands for flow through. E stands for elution.
doi:10.1371/journal.pone.0029204.g002
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(pEYFP-di-L D1R). Briefly, HEK 293 cells were transfected with
YFP-wild-type (wt) D1R or YFP-di-L D1R plasmid for cell surface
biotinylation and isolation studies using a kit from Thermo
Scientific Pierce. Twenty-four hours after transfection, the media
were aspirated and cells quickly washed twice with 5 mL of ice-
cold PBS per 10-cm dish. Then, 5 mL of the biotin solution were
added to each dish and gently agitated for 30 min at 4uC. The
reaction was stopped by the addition of 500 mL of quenching
solution. The rest of the steps followed the manufacturer’s
protocol. The samples were subjected to SDS-PAGE, and then
immunoblotted with anti-GFP antibody.
As shown in Fig. 2C, actin protein, which was used as a loading
control of the samples, indicated that the samples had same
amount of whole cell lysate (lanes W) before the elution. Much less
actin protein was detected in the eluted plasma membrane (lanes
E) because the actin protein is predominantly expressed inside the
cell. For the transfected cells, the soluble YFP bands (,30 kDa)
indicated similar transfection efficiency among the various
samples. It is clear that much more YFP-wt D1R (lane E;
,90 kDa) than YFP-di-L D1R proteins (lane E; ,70 kDa) were
eluted down after cell surface biotinylation and isolation. In other
words, YFP-wt D1R protein was mostly expressed at the cell
surface, but not the YFP-di-L D1R protein. This result is consistent
with the fluorescence microscopy studies shown in Fig. 2A.
Therefore, these results indicated that di-L motif in the C-
terminal of D1R plays a critical role in the plasma membrane
targeting of D1R. The cell surface isolation results also suggested
that the protein trafficked to the plasma membrane is glycosylated,
consistent with our previous reports [15].
Di-L mutant D1R is localized in early endosome
Since di-L mutant D1R was mainly localized in the intracellular
compartments, we determined the identity of these compartments.
We immunostained pYG2 (di-L mutant D1R)-transfected HEK
293 cells with the cis-Golgi marker, GM130, the endosomal
marker, EEA1, and the ER marker, calnexin. Di-L mutant D1R
did not colocalize with GM130 (Fig. 3A), colocalized partially with
calnexin (Fig. 3B), but colocalized mostly with EEA1 (Fig. 3C). By
using the Image J software, we calculated that ,20% of YFP-di-L
D1R proteins were colocalized with calnexin; but ,80% of YFP-
di-L D1R proteins were colocalized with EEA1, indicating that
most of YFP-di-L D1R proteins were localized in the early
endosomes. Each transfection was repeated four times, and
200,300 cells were observed in each coverslip. These data
indicated that di-L mutant could be transported from ER to the
Golgi region and subsequently to the endosomal compartments.
However, the di-L mutant D1R failed to be inserted into the
plasma membrane which is the final destination of wt D1R,
suggesting that the di-L motif in the C-terminus of D1R plays a
critical role in the plasma membrane targeting of D1R.
Glycosylation state of D1R
Given that the activity of several GPCRs depends on their
glycosylation status and plasma membrane trafficking [18], we
investigated the glycosylation state of both wt D1R and di-L
mutant D1R in transfected cells.
HEK 293 cells heterologously expressing the YFP-wt D1R and
YFP-di-L D1R proteins were treated with the N-lined glycosyla-
tion inhibitor tunicamycin (TUN). YFP-wt D1R migrated as a
band of ,90 kDa and a band of ,70 kDa in untreated cells
(Fig. 4A, ct) and in vehicle (DMSO)-treated cells, similar to those
shown in Fig. 2B. After tunicamycin treatment, YFP-wt D1R
migrated mainly as a band of ,70 kDa; the band of ,90 kDa was
much less compared to that in the non-TUN-treated cells,
indicating that the ,90 kDa YFP-wt D1R was glycosylated and
the protein of ,70 kDa was unglycosylated. In the untreated and
vehicle (DMSO)-treated YFP-di-L D1R cells (Fig. 4A), the major
band was ,70 kDa with a minor band of ,90 kDa, which were
also similar to those shown in Figure 2B. Tunicamycin treatment
minimally affected the ,90 kDa YFP-di-L, suggesting that a small
portion of di-L mutant D1R was also N-linked glycosylated. The
YFP tag did not interfere with the post-translational modification
of D1R proteins because similar results were obtained using non-
tagged D1R and di-L D1R (Fig. 4B); the bands were lower than
those in Fig. 4A because of the absence of the YFP tag.
Figure 3. Di-L mutant D1R was co-localized with the early
endosomes. (A) HEK 293 cells grown on the coverslips were
transfected with YFP-wt D1R and YFP-di-L D1R. ,36 h later, cells were
rinsed in cold PBS and fixed by 4% paraformaldehyde for 20 min on ice,
and then permeabilized by using methanol for 20 min on ice. The
following primary antibodies were used: monoclonal mouse anti-
GM130 (A), monoclonal mouse anti-calnexin (B), and polyclonal rabbit
anti-EEA (C). Alexa Fluor 568 donkey anti-mouse IgG and Alexa Fluor
568 donkey anti-rabbit IgG were the secondary antibodies. Mounting
medium with DAPI was used. Images were obtained on Olympus
Fluoview FV300 laser scanning confocal microscope equipped with a
40X 1.4 N.A. objective. Images were processed using Adobe Photoshop.
For each transfection experiment, at least four times were performed.
For each coverslip, 200,300 transfected cells were observed.
doi:10.1371/journal.pone.0029204.g003
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traversing the Golgi are N-glycosylated, whereas those residing in
the ER are high-mannose glycosylated [19]. Therefore, we
investigated the type of glycosylation of D1Rb yt r e a t i n gt h e
denatured cell lysates with Endo H to remove high-mannose N-
glycosylation, or peptide N-glycosidase F (PNGase F) to remove
both high-mannose and complex N-glycosylation (Fig. 4C). After
Endo H treatment, the ,80 kDa band (fully glycosylated non-
tagged D1R) was still visible in both wt and di-L mutant D1R,
suggesting that the D1R was not totally high-mannose N-
glycosylated. By contrast, PNGase F treatment resulted in the
migration of both wt D1R and di-L mutant D1Ra tt h e,60 kDa,
which corresponded to unglycosylated non-tagged D1R protein,
indicating that both wt and partial di-L mutant D1Rg o e s
through complex glycosylation, which occurs only in the Golgi
apparatus [20].
Cyclic AMP assay
To test the functionality of di-L mutant D1R and other C-
terminal mutants, we measured the accumulation of cyclic AMP
(cAMP) in the transfected cells that were treated with vehicle
(water) or fenoldopam, D1R agonist. To achieve similar transfec-
tion efficiency, HEK 293 cells were transfected with same amount
of each plasmid listed in Fig. 1B. We also visualized the cells under
the fluorescence microscope to further confirm their transfection
efficiencies (data not shown) before the treatment.
As stated above, RT-PCR and immunoblotting studies con-
firmed our previous reports that HEK 293 cells used in this study do
not endogenously express either D1Ro rD 5R (data not shown).
Therefore, as we expected, fenoldopam (1 mM, 15 min) did not
affect the cAMP accumulation in untransfected HEK 293 cells
(Fig. 5, untransfected), however, the wt D1R (pYG1)-transfected
HEK 293 cells had a marked increase in cAMP accumulation with
fenoldopam stimulation (Fig. 5A). Surprisingly, the accumulation of
cAMP in di-L mutant D1R (pYG2)-transfected cells in response to
fenoldopam was similar to wt D1R, although this mutant failed to
traffic to the cell surface (Figs. 2 and 3). Since fenoldopam is a
relatively cell-membrane permeable agonist (soluble to 12.2 mM in
water, but .31.1mM in DMSO, according to the datasheet from
the manufacturer), we hypothesized that fenoldopam that entered
the cell freely could bind to di-L D1Rs inside the cell but remain
functional. To test our hypothesis, we tested the ability of relatively
cell-membrane impermeable D1R agonist, A-68930 (soluble to
50 mM inwater, accordingto the datasheet from the manufacturer)
to increase cAMP accumulation in these cells (Fig. 5B). In this
experiment, cAMP accumulation did not increase in di-L mutant
D1R expressing cells. These results confirmed our hypothesis and
suggested that di-L motif plays an important role in the plasma
membranetargetingof D1R and its response to extracellular agonist
stimulation.
When palmitoylation site (Cys347) was mutated to serine
residue (347 C.S), accumulation of cAMP was not increased by
fenoldopam, indicating that palmitoylation of D1R is necessary for
agonist action (Fig. 5A, pYG8). The other mutant D1Rs (pYG3, 4,
5, 6, 7, 9, 10) in which the mutated sites were within the endocytic
recycling signal had an increase in cAMP accumulation in
response to fenoldopam stimulation, albeit to a much lower extent
than those observed in wt D1R. These results could be taken to
suggest that these mutants could be internalized as the wt after the
agonist stimulation, but are minimally recycled back to the plasma
membrane and therefore, respond minimally to continuous
agonist stimulation, thus the increase in cAMP was much lower
than that of the wt. However, this is unlikely because di-L mutant
D1R which is minimally trafficked to the plasma membrane had a
marked increase in cAMP response to the cell membrane
permeable but not cell membrane impermeable agonist. Rather,
these mutations interfered with the intrinsic ability of D1Rt o
respond to agonist stimulation, the mechanisms of which remain
to be determined.
Discussion
In general [21], GPCRs initially reside in the ER after synthesis,
where they undergo processing and folding guided by chaperone
and quality-control proteins. Following their exit from the ER,
GPCRs transit through the Golgi apparatus for additional
modifications. On the outer edge of the Golgi, GPCRs are
packaged in exocytic transport vesicles and enter the endosomal
system, where they are subsequently targeted to the plasma
membrane. After the extracellular agonist stimulation, the
activated GPCR acts as a guanine nucleotide exchange factor,
Figure 4. Glycosylation states of wt D1R and di-L mutant D1R
were analyzed by glycosylation inhibitors. (A) After an 8 hr
transfection, the HEK 293 cells heterologously expressing the YFP-wt
D1R and YFP-di-L D1R proteins were treated with or without tunicamycin
(1 mg/ml) for another 16 hr. Then the cells were collected for western
blotting. (B) After an 8 hr transfection, the HEK 293 cells heterologously
expressingthewtD1R anddi-LD1Rproteinswere treatedwith or without
tunicamycin (1 mg/ml) for another 16 hr. Then the cellswere collectedfor
western blotting to compare with Fig. 4A. (C) To determine the
oligosaccharides in the glycosylated D1R, 36 hr post-transfection, the
cells heterologously expressing wt D1R and di-L D1R proteins were
collected and denatured in glycoprotein denaturing buffers at 100uC for
10 min. Denatured sampled were digested with 500 U endoglycosidase
H or peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase A by
incubation at 37uC for 1 hour. After digestion, samples were subjected to
western blotting to analyze their state of glycosylation.
doi:10.1371/journal.pone.0029204.g004
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inducing dissociation of the Ga and Gbc subunits from each other
and from the GPCR. Activated GTP a subunits of which there are
multiple subtypes, including Gas, Gai, Ga12/13 and Gaq,
subsequently bind to and regulate the activity of effectors such
as adenylyl cyclase. Agonist binding also promotes GRK-mediated
phosphorylation of the cytoplasmic surface of GPCR and
subsequent b-arrestin translocation and binding to the receptor.
b-Arrestin binding, in turn, facilitates the subsequent recruitment
of AP-2 and clathrin and GPCR inclusion in clathrin-coated pits
before endocytosis via clathrin-coated vesicles. Most internalized
receptors may be either recycled to the plasma membrane or
sorted to lysosomes and proteasomes for degradation. The early
endosomes involved in GPCRs trafficking to the plasma
membrane are morphologically and functionally distinct and can
be identified by association with small GTPases called Rabs [22].
Furman et al. (2009) also showed for the first a functional role of
Rab 11 in the trafficking of dopamine receptor to the plasma
membrane [23], whereas sorting nexin 1 (SNX1) has more
recently been shown to play a role in endosomal to lysosomal
GPCR sorting [24]. As a GPCR, it is not clear yet how D1R
traffics in the cell and how its trafficking relates to the function,
although it has been reported that the C-terminus of D1R is very
important for its trafficking and function [8–9].
In this study, we investigated the plasma membrane trafficking
and function of a series of C-terminal mutant D1Rs in transfected
HEK 293 cells. Our results interestingly showed that when the di-
leucine motif (L344-345) at the C-terminus of D1R was mutated,
the mutant protein was not able to traffic to the plasma
membrane; instead, it was localized in the early endosome. This
data suggested that this C-terminal di-L motif is a plasma
membrane targeting signal. Kim et al. [25] reported that the cell
surface expression of a deletion mutant D1R (truncated at position
347) was diminished relative to the wild-type. In their mutant, di-L
motif was intact, but the mutant could not get to the cell surface.
Combined with our results, we propose that the di-L motif (L344-
345) is required for the cell surface targeting of D1R, but is not the
only signal for this trafficking. This C-terminal di-L motif is highly
conserved in GPCRs, but replacement of di-leucine motif in the C-
terminus of the b2-AR by alanines resulted in a marked reduction
in internalization [26], suggesting that di-leucine motif plays a
critical role in the endocytosis of b2-AR, which is similar to its
function in other membrane proteins [27–28].
Another common structural theme among GPCRs is palmitoy-
lation of one or more sites of the C-terminal tail near the seventh
transmembrane domain [29]. It has been shown that D1R has two
palmitoylation sites at positions 347 and 351 in the carboxyl tail
[30–31]. The substitution of Cys347 with a serine led to a
diminished ability to activate adenyly cyclase, indicating that
Cys347 is important for D1R in maintaining the conformation for
antagonist binding and is essential for D1R’s agonist-induced
desensitization, however, the pharmacological and functional
properties of C351S mutant were similar to that of wild-type
D1R [30]. In our study, we mutated Cys347 to serine residue
(construct of pYG8); the mutant protein was localized at the cell
surface (Fig. 2A), but failed to increase the accumulation of cAMP
in response to fenoldopam or A-68930 stimulation (Fig. 5). These
results further suggested that Cys347 is important for D1R
trafficking and responsiveness [32].
It has been known that N-glycans attached to the membrane
proteins can act as a plasma membrane sorting signal, but it
does not ensure their distribution to the plasma membrane. For
example, inhibiting the glycosylation of D1Rd e c e a s e dt h ec e l l
surface trafficking of D1R [17], however, these results contrast
with those of Karpa et al. [33], who found that N-linked
glycosylation was not required for D1R localization to the
plasma membrane. The reason(s) for this discrepancy is not
clear. In this study, we found that the glycosylation of YFP-di-L
D1R was markedly decreased and markedly limited expression
at the cell surface compared with the wild-type (Figs. 2 & 4),
which is consistent with the finding of Free et al.[17], indicating
that the glycosylation is required for the cell surface trafficking
of D1R. To determine the type of N-linked glycosylation of
D1R, we treated the cells with Endo H and PNGase F; PNGase
F can remove all N- linked carbohydrates (complex N-glycans)
without regard to type, whereas Endo H removes only high
mannose and some hybrid types of N-linked carbohydrates. The
results in Fig. 4C clearly showed that the glycosylation of D1Ri s
that of complex N-glycosylation. This glycosylation state may
explain why YFP-di-L D1Rs (Fig. 3), which are minimally
glycosylated were localized in the early endosome but not in the
Golgi or endoplasmic reticulum (ER), because the majority of
mature glycoproteins that traverse the Golgi carry complex N-
glycans [19].
Figure 5. Di-L mutant D1R has an impaired ability to increase
cAMP accumulation activity in response to A-68930. HEK 293
cells were transfected with same amount of each plasmid as indicated.
24 hours later, cells were treated with or without 1 mM of fenoldopam
(A) or 1 mM of A-68930 for 15 min. The cAMP direct immunoassay kit
was used for measuring the production of cAMP. Each treatment was
performed in triplicate. Data were expressed as mean 6 standard error.
Significance between groups was determined by Student’s t test. A P
value , 0.05 was considered significant.
doi:10.1371/journal.pone.0029204.g005
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ability to increase cAMP accumulation after agonist stimulation.
Surprisingly, di-L mutant D1R (pYG2 in Fig. 5A), which was not
localized at the cell surface membrane but rather inside the cell,
increased cAMP accumulation in response to fenoldopam to a
similar extent as wt D1R. Because fenoldopam (selective D1R
agonist, in the absence of D5R) is relatively cell-membrane
permeable we hypothesized that fenoldopam could bind to the di-
LD 1Rs that continue to be functional inside the cell. However,
when the cells were treated with A-68930 (also a selective D1R
agonist, in the absence of D5R), which is a relatively cell-
membrane impermeable, the accumulation of cAMP was not
affected. These data indicated that the response of di-L mutant
D1R to extracellular agonist stimulation was impaired because of a
failure of di-L mutant D1R to be trafficked to the plasma
membrane. The mutants other than pYG2 had a limited cAMP
response to both fenoldopam and A-68930, probably because of
impairment of function, not necessarily related to cell surface
membrane trafficking. It could be that they have greatly
diminished resensitization or they cannot find Gs and/or cylase
in early/recycling endosomes.
In summary, di-L motif (L344-345) at the C-terminus of D1Ri s
required for its plasma membrane trafficking and glycosylation.
Further investigations may reveal how di-L motif is involved in the
sorting of D1R.
Supporting Information
Figure S1 Western blots using anti- D1R antibody. HEK
293 cells were transfected with YFP-wt D1R and YFP-di-L D1R
plasmids in 6-well plates. 36 hours after transfection, cells were
washed twice with ice-cold PBS and then lysed in cold RIPA
buffer containing 1 mM DTT and protease and phosphatase
inhibitors on ice for 10 min. The cell lysates were subjected to
SDS-polyacryalmide gel electrophoresis (4–12% gradient gel) and
immunoblotted with rabbit anti-D1R antibody.
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